Top Scientists Leading Tomorrow's Treatments

Ymmunobio is committed to developing preclinical breakthroughs toward improving how cancer therapies are developed.

 

Dr. Katrin Rupalla & Dr. Peter Schiemann co-founded Ymmunobio in 2021 as a way to advance developments in solid tumor research. Since that time, Ymmunobio has assembled a distinguished team of scientific and clinical leaders who are united in transforming how cancer and autoimmune diseases are treated.